ARTICLE | Clinical News
rhBMP-2/ACS recombinant protein bone graft substitute regulatory update
May 10, 2004 7:00 AM UTC
FDA granted marketing approval for rhBMP-2/ACS to treat acute, open tibia shaft fractures in adults. Medtronic Inc. (MDT, Minneapolis, Minn.) has worldwide rights to market the compound for the indic...